| RS568852704 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS568853401 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS568865061 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, PCDH15-related disorder |
| RS568865339 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS568867325 |
RAG1
|
Health Risk |
Pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS568871363 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS568880098 |
IFITM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, IFITM5-related disorder |
| RS568885234 |
IVD
|
Health Risk |
Pathogenic/Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS568886353 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset myopathy with fatal cardiomyopathy, Myopathy |
| RS568895329 |
MATR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 21, Amyotrophic lateral sclerosis type 21 |
| RS568898016 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS568899040 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS568899945 |
XYLT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, XYLT1-related disorder |
| RS568902441 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS568913937 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS568921640 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS568924674 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS568924861 |
STRA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS568925019 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Inborn genetic diseases |
| RS568930062 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
PDE6C-related disorder, PDE6C-related disorder |
| RS568936247 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS568942029 |
TONSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Sponastrime dysplasia, TONSL-related disorder |
| RS568949451 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 10, Retinitis pigmentosa |
| RS568950079 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS568952207 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome |
| RS568958746 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Donnai-Barrow syndrome |
| RS568959118 |
GRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 3, Fraser syndrome 3 |
| RS568964531 |
HR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS568969576 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS568980956 |
CTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, Cerebroretinal microangiopathy with calcifications and cysts 1 |
| RS568986390 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS569003242 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS56900494 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS569024726 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS569032124 |
USH1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS569040282 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Inborn genetic diseases |
| RS569060938 |
COX6B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS569061665 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS569071678 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS569086883 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS569088856 |
PJVK
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 59, Autosomal recessive nonsyndromic hearing loss 59 |
| RS569112173 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2, Usher syndrome type 2 |
| RS569119560 |
IARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth retardation, intellectual developmental disorder |
| RS56912727 |
SEMA6A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS569127795 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS569129411 |
TMEM70
|
Health Risk |
Likely pathogenic |
— |
| RS569131932 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypersulfaturia, Nephrolithiasis susceptibility caused by SLC26A1 |
| RS569152308 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 1, isolated |
| RS569159249 |
WHRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 31, Usher syndrome type 2D |
| RS569172957 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS569180524 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, CBL-related disorder |
| RS569180795 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS569192835 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome, HPS1-related disorder |
| RS569193097 |
GRXCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing impairment, Hearing impairment |
| RS569195112 |
SCNN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 2, Pseudohypoaldosteronism |
| RS569199683 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS569203312 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS569220214 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS569222899 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Transitory neonatal diabetes mellitus |
| RS569225834 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS56922686 |
KRT5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS569240271 |
DNAJC12
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperphenylalaninemia due to DNAJC12 deficiency, Hyperphenylalaninemia due to DNAJC12 deficiency |
| RS569241534 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS569242465 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Robinow syndrome, Brachydactyly type B1 |
| RS569254423 |
LHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Combined pituitary hormone deficiencies |
| RS569260441 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS569268772 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS569274233 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS569286722 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS569293775 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO7A-related disorder, MYO7A-related disorder |
| RS569297468 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS569301210 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, TRPM4-related disorder |
| RS569302875 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperinsulinism, Maturity-onset diabetes of the young type 1 |
| RS56930579 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS569306063 |
UNC45A
|
Health Risk |
Conflicting classifications of pathogenicity |
UNC45A-related disorder, Inborn genetic diseases |
| RS569310979 |
QDPR
|
Health Risk |
Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS569311945 |
RAB18
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 3, Warburg micro syndrome 3 |
| RS569323391 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS569342451 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachyolmia-amelogenesis imperfecta syndrome, Inborn genetic diseases |
| RS569343097 |
PIEZO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Gordon syndrome |
| RS569343105 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS569346627 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS569351854 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS569356297 |
ZFPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Diaphragmatic hernia 3, 46 |
| RS569356622 |
TAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class I deficiency, MHC class I deficiency |
| RS569364202 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 4, Nephronophthisis |
| RS569372725 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS569375203 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS569378409 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4C, Susceptibility to mononeuropathy of the median nerve |
| RS569379713 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS569386009 |
PIGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 3, Inborn genetic diseases |
| RS569392655 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS569395274 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS569406301 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary erythromelalgia, Paroxysmal extreme pain disorder |
| RS569422992 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS569425024 |
ZFHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS569428035 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS569428131 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Malignant tumor of breast |
| RS569432039 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS569444237 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 1 |